Deals
Pfizer Still Wants AstraZeneca After Bid Rejected
This article is for subscribers only.
Pfizer Inc. is back in the megamerger game.
The U.S. drugmaker proposed buying AstraZeneca Plc for about 58.8 billion pounds ($98.7 billion) in what would rank as the industry’s biggest-ever takeover, surpassing Pfizer’s $64 billion purchase of Wyeth in 2009. AstraZeneca spurned the offer as too low, and Pfizer said it’s considering its options.